Deal of the Day — limited-time pharmacy picks!
Janumet XR CP CO Pack Tablet

Janumet XR CP CO Pack Tablet

Salt Composition: Sitagliptin (100mg) + Metformin (1000mg)

Expiry Date: 01/2028

Special offer

Buy at $14.59

$14.59

Inclusive of all taxes

▼

7 Tablet in a Strip

About The Product

 For patients who prefer once-daily dosing and extended sugar control throughout the day.

Description

Janumet XR CP CO Pack Tablet is an anti-diabetic medicine. It is a combination of Sitagliptin (100mg) and Metformin (1000mg).

It is prescribed to treat type 2 diabetes mellitus in adults. It works by controlling high blood sugar levels in people with diabetes and also prevents from serious complications related with diabetes such as kidney damage, blindness and may also reduce chances of having a heart attack or stroke.

It should be taken with food at the same time each day to get effective results. Don't take more than the recommended dose

Uses

  • Type 2 diabetes mellitus

Side Effects

Janumet XR CP CO Pack Tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:

  • Headache
  • Diarrhea
  • Upper respiratory tract infection

Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

  • Take Janumet XR CP CO Pack Tablet in dosage as prescribed by the doctor. Dosage and the duration determined as per the patients health condition.
  • This tablet should be swallowed as a whole with water. Don't crush, chew, or break the tablet. It should be taken with food. Never skip a dose or double dose.


How It Works

  • Janumet XR CP CO Pack Tablet is an anti-diabetic medicine. It is a combination of Sitagliptin (100mg) and Metformin (1000mg). As a sulfonylurea, sitagliptin minimizes blood sugar by stimulating the pancreas to secrete more insulin.
  • Metformin is a biguanide that increases the body's tolerance to insulin, reduces the liver's synthesis of glucose, and slows down the intestines' absorption of glucose.


Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Janumet XR CP CO Pack Tablet, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Pregnancy
Do not take Janumet XR CP CO Pack Tablet without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Breast Feeding
Breastfeeding women should discuss the potential risks and benefits of the Janumet XR CP CO Pack Tablet with their healthcare provider before starting treatment.
Driving
Janumet XR CP CO Pack Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Kidney
Share your medical history with the doctor before starting the Janumet XR CP CO Pack Tablet. Do not take it without consulting a doctor if you have any kidney related issue.
Liver
Share your medical history with the doctor before starting the Janumet XR CP CO Pack Tablet. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

Janumet XR CP CO Pack Tablet is consist of two anti-diabetic medicines such as Sitagliptin (100mg) and Metformin (1000mg).

References

  • Goldstein, B. J., Feinglos, M. N., Lunceford, J. K., Johnson, J., Williams-Herman, D. E., & Sitagliptin 036 Study Group. (2007). Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. Diabetes care, 30(8), 1979-1987. https://pubmed.ncbi.nlm.nih.gov/17485570/
  • Hayes, J., Anderson, R., & Stephens, J. W. (2016). Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy. Drug Design, Development and Therapy, 2263-2270. https://pubmed.ncbi.nlm.nih.gov/27486305/
  • Williams-Herman, D., Johnson, J., Teng, R., Luo, E., Davies, M. J., Kaufman, K. D., ... & Amatruda, J. M. (2009). Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study. Current Medical Research and Opinion, 25(3), 569-583. https://pubmed.ncbi.nlm.nih.gov/19232032/
  • Chwieduk, C. M. (2011). Sitagliptin/metformin fixed-dose combination: in patients with type 2 diabetes mellitus. Drugs, 71(3), 349-361. https://pubmed.ncbi.nlm.nih.gov/21319871/
  • Williams‐Herman, D., Johnson, J., Teng, R., Golm, G., Kaufman, K. D., Goldstein, B. J., & Amatruda, J. M. (2010). Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 12(5), 442-451. https://pubmed.ncbi.nlm.nih.gov/20415693/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026